- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01109303
Static Implant Versus Dynamic Implant in the Surgical Treatment on Ankle Syndesmosis Rupture
Prospective Randomized Multicentric Trial Comparing a Static Implant and a Dynamic Implant in the Surgical Treatment of Ankle Syndesmosis Rupture
Ankle fracture is frequent and its number is increasing. In Canada, surgical treatment of these lesions is advised and the options currently used all have in common a rigid fixation of the syndesmosis which results in residual stiffness and a high level of secondary surgery, mostly to remove the implant.
The purpose of the study is to compare the treatment of ankle syndesmotic rupture by a dynamic fixation to a static fixation suggesting that the dynamic fixation method will improve the Olerud-Molander functional score of more than 15 points at the 3 months follow-up.
Study Overview
Status
Conditions
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Quebec
-
Québec, Quebec, Canada, G1J 1Z4
- CHA-Pavillon Enfant-Jésus
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- men or women ≥ 18 years-old;
- ankle fracture type 44-C (AO classification) with an AP, lateral and mortise X-ray views of the ankle and an AP and lateral X-ray views of the leg;
- open fractures (Gustilo I-IIIb) or closed;
- trauma-surgery delay of less than 7 days;
- consent form signed.
Exclusion Criteria:
- ankle fractures without syndesmotic lesion;
- fracture associated with neuro-vascular lesions (Gustillo IIIc);
- pathologic fracture;
- fracture in a polytraumatized patient;
- fracture of a bone in the ipsilateral leg;
- men or women > 65 years-old;
- chronic cardiac insufficiency (ejection fraction < 30%);
- lower leg chronic venous insufficiency;
- neuro-arthropathic foot (Charcot, diabetes, etc…);
- body mass index ≥ 40;
- past medical history of fracture of the same ankle;
- medical conditions too serious for a surgery;
- men or women unfit to consent;
- any other conditions that make the examinator thinks that the follow up would be problematic.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: TightRope System
Patients are operated on using the TightRope implant by Arthrex.
|
Patients are operated on using a dynamic implant, the TightRope System by Arthrex®.
The ankle is immobilized in a plaster boot for 6 weeks.
|
Active Comparator: Screw fixation implant
Patients are operated on using the rigid four-cortices 3,5 mm screw fixation by Synthes.
|
Patients are operated on using a static implant, the rigid four-cortices 3,5 mm screw fixation by Synthes®.
The ankle is immobilized in a plaster boot for 6 weeks.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Olerud-Molander score
Time Frame: 3 months after surgery
|
The Olerud-Molander scoring scale was chosen because it adequately represents the ankle performance following surgery (trauma or elective basis).
It comprises nine functional parameters which are concerned with primary complaints, the ability to perform simple tasks and the everyday life activities.
|
3 months after surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Rate of secondary surgery
Time Frame: within one year following surgery
|
To measure the rate of secondary surgery due to infection or implant removal.
Every secondary surgery during the following year counts, even for the same patient.
|
within one year following surgery
|
Radiological loss of reduction
Time Frame: 2 weeks after surgery
|
Adequate reduction of the syndesmosis is evaluated on a simple X-ray in the anteroposterior (AP) and mortise views; the "clear space" is the distance between the medial side of fibula and the incisural surface of tibia (1 cm above tibial pilon) and cannot be more than 6 mm. Rate of loss of reduction and the range of this loss over 6 mm will be calculated in each group. |
2 weeks after surgery
|
Implant failure
Time Frame: one year after surgery
|
Rate of implant failure (with or without a second surgery for removal) will be measured in each group.
|
one year after surgery
|
Radiological loss of reduction
Time Frame: 6 weeks after surgery
|
Adequate reduction of the syndesmosis is evaluated on a simple X-ray in the AP and mortise views; the "clear space" is the distance between the medial side of fibula and the incisural surface of tibia (1 cm above tibial pilon) and cannot be more than 6 mm. Rate of loss of reduction and the range of this loss over 6 mm will be calculated in each group. |
6 weeks after surgery
|
Radiological loss of reduction
Time Frame: 12 weeks after surgery
|
Adequate reduction of the syndesmosis is evaluated on a simple X-ray in the AP and mortise views; the "clear space" is the distance between the medial side of fibula and the incisural surface of tibia (1 cm above tibial pilon) and cannot be more than 6 mm. Rate of loss of reduction and the range of this loss over 6 mm will be calculated in each group. |
12 weeks after surgery
|
Radiological loss of reduction
Time Frame: 6 months after surgery
|
Adequate reduction of the syndesmosis is evaluated on a simple X-ray in the AP and mortise views; the "clear space" is the distance between the medial side of fibula and the incisural surface of tibia (1 cm above tibial pilon) and cannot be more than 6 mm. Rate of loss of reduction and the range of this loss over 6 mm will be calculated in each group. |
6 months after surgery
|
Radiological loss of reduction
Time Frame: 12 months after surgery
|
Adequate reduction of the syndesmosis is evaluated on a simple X-ray in the AP and mortise views; the "clear space" is the distance between the medial side of fibula and the incisural surface of tibia (1 cm above tibial pilon) and cannot be more than 6 mm. Rate of loss of reduction and the range of this loss over 6 mm will be calculated in each group. |
12 months after surgery
|
American Orthopaedic Foot and Ankle Society (AOFAS) score of hindfoot
Time Frame: 12 weeks after surgery
|
An evaluation of the function (7 criteria), alignment (1 criteria) and pain (1 criteria), for a maximum of 100 points on the AOFAS scale.
|
12 weeks after surgery
|
AOFAS score of hindfoot
Time Frame: 6 months after surgery
|
An evaluation of the function (7 criteria), alignment (1 criteria) and pain (1 criteria), for a maximum of 100 points on the AOFAS scale.
|
6 months after surgery
|
AOFAS score of hindfoot
Time Frame: 12 months after surgery
|
An evaluation of the function (7 criteria), alignment (1 criteria) and pain (1 criteria), for a maximum of 100 points on the AOFAS scale.
|
12 months after surgery
|
Return to professional activities
Time Frame: 3 months after surgery
|
This measure will be determined in days after surgery, for rate of 50% and 100% of the usual work load.
|
3 months after surgery
|
Pain on visual analog scale (VAS)
Time Frame: 12 weeks after surgery
|
Pain is described with the VAS, which ranges from 1 to 10.
|
12 weeks after surgery
|
Pain on VAS
Time Frame: 12 weeks after surgery
|
Pain is described with the VAS, which ranges from 1 to 10.
|
12 weeks after surgery
|
Pain on VAS
Time Frame: 12 months after surgery
|
Pain is described with the VAS, which ranges from 1 to 10.
|
12 months after surgery
|
Range of motion
Time Frame: 12 weeks after surgery
|
With a goniometer, a measure of the dorsal flexion (normal value 20°) and plantar flexion (40°) will be taken.
Inversion and eversion will be measured according to this scale: + = weak ; ++ = middle ; +++ = complete.
|
12 weeks after surgery
|
Range of motion
Time Frame: 6 months after surgery
|
With a goniometer, a measure of the dorsal flexion (normal value 20°) and plantar flexion (40°) will be taken.
Inversion and eversion will be measured according to this scale: + = weak ; ++ = middle ; +++ = complete.
|
6 months after surgery
|
Range of motion
Time Frame: 12 months after surgery
|
With a goniometer, a measure of the dorsal flexion (normal value 20°) and plantar flexion (40°) will be taken.
Inversion and eversion will be measured according to this scale: + = weak ; ++ = middle ; +++ = complete.
|
12 months after surgery
|
Muscular trophicity measure of the leg
Time Frame: 12 weeks after surgery
|
This measure is taken with a metric band 15 cm under the inferior patellar pole and must be compared to normal side.
It is defined in cm with a precision of 0.5 cm.
A ratio injured side/normal side will be calculated.
|
12 weeks after surgery
|
Muscular trophicity measure of the leg
Time Frame: 6 months after surgery
|
This measure is taken with a metric band 15 cm under the inferior patellar pole and must be compared to normal side.
It is defined in cm with a precision of 0.5 cm.
A ratio injured side/normal side will be calculated.
|
6 months after surgery
|
Muscular trophicity measure of the leg
Time Frame: 12 months after surgery
|
This measure is taken with a metric band 15 cm under the inferior patellar pole and must be compared to normal side.
It is defined in cm with a precision of 0.5 cm.
A ratio injured side/normal side will be calculated.
|
12 months after surgery
|
Ankle circumference measure
Time Frame: 12 weeks after surgery
|
This measure is taken with a metric band at the bimalleolar level and must be compared to normal side.
It is defined in cm with a precision of 0.5 cm.
A ratio injured side/normal side will be calculated.
|
12 weeks after surgery
|
Ankle circumference measure
Time Frame: 6 months after surgery
|
This measure is taken with a metric band at the bimalleolar level and must be compared to normal side.
It is defined in cm with a precision of 0.5 cm.
A ratio injured side/normal side will be calculated.
|
6 months after surgery
|
Ankle circumference measure
Time Frame: 12 months after surgery
|
This measure is taken with a metric band at the bimalleolar level and must be compared to normal side.
It is defined in cm with a precision of 0.5 cm.
A ratio injured side/normal side will be calculated.
|
12 months after surgery
|
Collaborators and Investigators
Sponsor
Collaborators
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- PEJ-446
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Ankle Syndesmosis Rupture
-
University of NebraskaRecruitingAcute Disruption of Ankle SyndesmosisUnited States
-
Spaarne GasthuisCompletedAnkle Injuries | Acute Ankle Sprain | Ankle Ligament RuptureNetherlands
-
Federal University of Minas GeraisCompletedAnkle Fractures | Achilles Tendon Rupture | Ankle Sprains | Ankle Dislocations | Ankle BruisesBrazil
-
Federal University of São PauloCompletedAnkle Injuries | Ankle Fractures | Ligament Rupture | Deltoid Ligament; Sprain (Strain) (Ankle)Brazil
-
Finnish Defense ForcesCompleted
-
Vann Virginia Center for Orthopaedics dba Atlantic...Arthrex, Inc.Active, not recruitingLigament Rupture | Syndesmotic Injuries | Bimalleolar Fractures | Trimalleolar FracturesUnited States
-
Goztepe Training and Research HospitalRecruitingAnkle Fractures | Ligament Rupture | Ligament InjuryTurkey
-
Karolinska University HospitalIstituto Ortopedico Rizzoli; Sahlgrenska University Hospital, Sweden; University... and other collaboratorsRecruitingVenous Thromboembolism | Ankle Fractures | Achilles Tendon RuptureSweden
-
Paragon 28CompletedAnkle Injuries | Achilles Tendon Rupture | Ankle Sprains | Syndesmotic Injuries | Ankle Inversion Sprain | Flexor Digitorum Longus on the Right | Flexor Digitorum Longus on the Left | Deltoid Ankle Sprain | Flexor Hallucis Longus on the Left | Flexor Hallucis Longus on the RightUnited States
-
Liming ChengUnknown
Clinical Trials on TightRope System- Arthrex® / Dynamic Implant
-
J&M ShulerCompletedThumb Carpometacarpal ArthritisUnited States
-
University of BarcelonaUnknown
-
Western Galilee Hospital-NahariyaUnknown
-
Western Galilee Hospital-NahariyaUnknownMaxillary SinusitisIsrael
-
Applied Spine TechnologiesTerminatedLumbar Spinal StenosisUnited States
-
CereVasc IncAlvaMed, Inc.; Simplified Clinical Data Systems, LLC; Bioscience Consulting,...TerminatedPilot Study to Evaluate the CereVasc® eShunt® System in the Treatment of Communicating HydrocephalusHydrocephalus | Hydrocephalus, CommunicatingUnited States
-
Ostomycure ABDevicia ABUnknownIleostomy - StomaSweden, United Kingdom
-
CochlearNAMSARecruitingHearing Loss, Unilateral | Deafness, UnilateralUnited States
-
Active ImplantsActive, not recruitingOsteoarthritis, Knee | Post-Meniscectomy Pain SyndromeUnited States
-
Chang Gung Memorial HospitalNational Science Council, TaiwanCompletedObstructive Sleep Apnea | Primary SnoringTaiwan